Skip to main content
Caplight Logo









Innocens BV

Innocens BV

Private
AntwerpHealthcare & Life Scienceshttps://innocens.be/

Last Round

VC Round

Nov 27, 2025

Total Funding Raised

$110,000

Company Overview

Innocens BV is a health technology company that develops an AI-powered clinical decision support system for the early detection of sepsis in neonatal intensive care units.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Health IoT

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical decision support systemCDSSneonatal intensive careNICUmedical AIsepsis detectionpredictive analyticsdigital healthhealthtechpatient monitoringvertical SaaShealthcare analyticsclinical AIfederated learningedge computing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innocens BV Comparables

Compare Innocens BV with similar companies based on industry and business-model similarity.

Innocens BV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Child Health Imprints
88%
NeoPrediX AG
85%
Aisthesis Medical
80%

Innocens BV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 27, 2025
GrantMar 18, 2024

Key People

Founding team and executive leadership

David Van Laere

CEO

Executive Team

Charlie Beirnaert

Chief Technology Officer

Executive Team

Innocens BV Investors

Notable investors and investment history

Innocens BV investors
InvestorRounds
LRMVC Round
Business Angels Network FlandersVC Round
City of AntwerpGrant
BeAngelsVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2026

    Monthly visitors grew 194% MoM, reaching 1.9K.

  • Jan 30, 2025

    Monthly visitors increased 44% MoM, reaching 1.1K.

Innocens BV Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Innocens BV Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Innocens BV's valuation, stock price, and market status.

Firmographic Details

HeadquartersAntwerp
Employee Range8
Year Founded2021
Last FundingNov 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?